A case of polycythæmia is herewith reported, showing the result of treatment by phenylhydrazine hydroehloride.
The daily intake of protein was limited to 50 grammes to offset the possibility of an elevation of the blood urea, during the period of intensive treatment.
It is suggested that this mode of treatment is quite safe in very many cases of polyeythæmia, and is more easily available than other forms of treatment.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Hofheinz:Dtches. Arch. f. Klin. Med., 1929, 163, 1.
Friedemann u. Deicher:Klin. Wchschr., 1929, 8, 385.
Hoppe-Seyler:Ztschr. f. Physiol. Chem., 1885, 11, 34.
Morawitz u. Pratt:Münch, med. Wchschr., 1908, ii, 1817.
Eppinger u. Kloss:Therap. Monaths., 1918, 32, 322.
Bryan:Trans. Phys. Mayo Clinic, 1927, viii, 58.
Brown and Giffin:Arch. Int. Med., 1926, 38, 321.
Allen and Giffin:Arch. Int. Med., 1928, 1, 676.Ibid., 677.
Giffin & Conner:Jo. Am. Med. Ass’n., 92, 18, 1505.
From Limerick County Hospital, Croom.
About this article
Cite this article
Honan, M.S., Madden, V. The use of phenylhydrazine hydrochloride in polycythæmia. Ir J Med Sci 4, 671–673 (1929). https://doi.org/10.1007/BF02951292